ACQUIRED · 2019
Who Acquired 21st Century Oncology, Inc.?
GenesisCare · $1.10B· 9.2× EBITDA
The acquisition
21st Century Oncology, Inc. was acquired by GenesisCare in 2019 for $1.10B. The deal was priced at 9.2× EBITDA.
21st Century Oncology, Inc. at time of acquisition
EBITDA
$120.0M
Deal value
$1.10B
EV / EBITDA
9.2×
Similar medical practice specialty acquisitions
- Consulting Cardiologists · acquired by Hartford HealthCare in 2026 · $3.0M
- EyeSouth Partners' Retina Business · acquired by Cencora, Inc. in 2026 · $1.10B
- OneOncology · acquired by Cencora, Inc. in 2025 · $7.40B
- OrthoAlliance · acquired by Optum / SCA Health in 2025 · $1.40B
- OrthoNY · acquired by Zenyth Partners / Evolve Orthopedic Partners in 2025 · $110.0M
Run a valuation for a similar medical practice specialty business
Three fields, instant range, backed by 25,592 real M&A transactions including this one.
Open the medical practice specialty calculator →More on medical practice specialty valuations
- Medical Practice Specialty valuation calculator· head-term variant
- Medical Practice Specialty median multiples· real-deal benchmarks
- How to value a medical practice specialty· long-form guide
Sourced from Press reporting. Full deal page.
Citation: ExitValue.ai. (2019). 21st Century Oncology, Inc. acquired by GenesisCare. https://exitvalue.ai/acquired/21st-century-oncology-inc